Buprenorphine
- TRADE NAMES: Probuphine (Braeburn); Suboxone (Reckitt Benckiser); Subutex (Reckitt Benckiser); Temgesic; Transtec (Napp)
- INDICATIONS: Opioid dependence, moderate to severe pain
- CLASS: Analgesic, Mixed opioid agonist/antagonist, Narcotic
- HALF-LIFE: 37 hours
Antihistamines, Atazanavir, Azole antifungals, Benzodiazepines, Boceprevir, Carbamazepine, Cimetidine, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Delavirdine, Diazepam, Efavirenz, Erythromycin, HIV protease inhibitors, Hydrocodone, Hydromorphone, Ketoconazole, Ketorolac, Linezolid, Macrolide antibiotics, Morphine, Neuroleptics, Oliceridine, Oxymorphone, Phenobarbital, Phenytoin, Rifampin, Ritonavir, Tapentadol, Tipranavir
PREGNANCY CATEGORY: C
Suboxone contains naloxone; Probuphine is an implant for subdermal administration.
ABUSE POTENTIAL, LIFE-THREATENING RESPIRATORY DEPRESSION, and ACCIDENTAL EXPOSURE
Probuphine: IMPLANT MIGRATION, PROTRUSION, EXPULSION, and NERVE DAMAGE ASSOCIATED WITH INSERTION and REMOVAL
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric